Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error (with minimal 403 page content) instead of rendering the study record, indicating restricted access or a loading/navigation problem.
    Difference
    19%
    Check dated 2026-09-22T22:45:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, Revision: v3.7.0, replacing the prior v3.6.6. This indicates the document or component has been updated to a newer version.
    Difference
    0.1%
    Check dated 2026-09-15T21:35:12.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, reflecting a platform-level update; the study details themselves remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-01T18:17:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study's list of identifiers now includes a line for '2014 ( U.S. NIH Grant/Contract )', indicating NIH funding for the trial.
    Difference
    0.1%
    Check dated 2026-08-25T20:48:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5, replacing v3.6.4, indicating a deployed software update to the site rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-11T16:56:43.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, indicating a newer build of the site's underlying templates or scripts. This typically reflects minor fixes or updates to the page infrastructure rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-07-28T10:24:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.